The investigational, oral selective estrogen receptor degrader (SERD) giredestrant given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with ...
Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or ...
AllAfrica on MSN
HIV cure must not be a privilege
Scientists have confirmed the tenth person in the world to achieve long-term HIV remission without antiretroviral medication, thanks to a stem cell transplant that has kept them virus-free for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback